Ozempic (semaglutide) helps with weight loss in non-diabetics by mimicking the natural hormone GLP-1, which slows stomach emptying, reduces appetite, and tells the brain you're full, leading to eating less and consuming fewer calories. While approved for diabetes, it's used off-label for weight management, with Wegovy being the same drug at a higher dose for obesity, and requires lifestyle changes (diet/exercise) for best results and to prevent weight regain.
Ozempic works by mimicking a naturally occurring hormone. As those hormone levels rise, the molecules go to your brain, telling it you're full. It also slows digestion by increasing the time it takes for food to leave the body.
Still, the FDA has not yet granted full approval for tirzepatide as a weight-loss drug for non-diabetics. For now, its use in that context is considered “off-label,” meaning doctors can prescribe it based on their own clinical judgment.
Tricyclic antidepressants (TCAs) such as amitriptyline are associated with weight gain and potential insulin resistance, which may counteract the glucose-lowering effects of Ozempic.
You feel full for a longer period of time (satiety), so you're likely to eat less. One study of 30 people showed that GLP-1 medications like Ozempic may also help your body burn fat.
Will Ozempic or Wegovy reduce belly fat? The answer appears to be yes. That Novo Nordisk-funded study of almost 2,000 overweight or obese adults without diabetes also found their visceral fat — the type that accumulates in the belly — was reduced from baseline with semaglutide, along with their total fat mass.
But about half of people with obesity on this class of medications, called glucagon-like peptide agonists or GLP-1s, stop taking it within a year. Studies suggest that most people discontinue their use due to the high cost and adverse gastrointestinal side-effects.
Medical Contraindications for Ozempic
Improved blood sugar control: Ozempic helps regulate blood sugar levels, reducing the risk of complications associated with diabetes, including cardiovascular disease [1]. Lowering blood pressure: Studies suggest Ozempic may help lower blood pressure, further contributing to cardiovascular protection [7].
On average, losing 30 pounds occurs within 5-6 months of sustained treatment.
"Ozempic face" as a side effect of GLP-1 drugs
The best places on your body to inject Ozempic® are the front of your thighs, the front of your waist (abdomen) or your upper arms. It is recommended that you rotate your injection site each time you inject. After 4 weeks, your dose should be increased to 0.5 mg once a week, unless otherwise informed by your doctor.
Non-diabetic patients prescribed semaglutide have an increased likelihood of delayed gastric emptying and gallstones compared to those on other weight loss medications.
Ozempic can also affect the reward centers in the brain that release dopamine, which gives people pleasure from eating certain kinds of foods. While on Ozempic, a person may find eating certain kinds of foods less gratifying, which can help reduce calorie intake during the day.
“Some patients will experience a loss of appetite with the initial dose,” he says. “However, most patients will likely not see significant weight loss until they reach higher dose levels at eight-to-12 weeks.” In Dr. Lofton's experience, there is usually some weight loss in the first month.
"Ozempic face" (rapid facial fat loss and sagging) doesn't automatically go away, but it can improve if you regain weight, or you can treat it with fillers, microneedling, or other cosmetic procedures, though the underlying effects often persist if weight loss is maintained. The appearance of "Ozempic face" is due to quick fat loss, reducing the skin's support, and while skin elasticity can help some younger individuals, older adults with less collagen often see persistent sagging.
Key Milestones for Weight Loss with Ozempic
"Ozempic hands" is a slang term for the skeletal or aged appearance hands can develop due to rapid fat loss from medications like Ozempic (semaglutide), where thinner skin reveals more prominent veins, tendons, and bones, resulting in a loss of fullness. It's not a formal diagnosis but describes a visible sign of significant weight loss, similar to "Ozempic face" or "Ozempic feet," caused by reduced subcutaneous fat and skin not contracting quickly enough.
In a statement that could affect millions of Americans, the American College of Cardiology released new clinical guidance encouraging physicians to “embrace” the use of GLP-1 receptor agonists — popularly known as weight-loss drugs such as Wegovy and Ozempic — for patients with obesity and heart disease.
It's unusual, but Ozempic can paralyze the stomach – a condition called gastroparesis. The muscle contractions in the stomach become so weak that the stomach can't digest food and push it forward into the intestines. This can result in food sitting in the stomach for too long.
Candidates for Ozempic treatment for weight loss include individuals who have a BMI of 30 or higher and those with a BMI of 27 or higher as well as at least one weight-related condition, such as high blood pressure, high cholesterol, or type 2 diabetes.
Yes, most people regain a significant amount of weight after stopping Ozempic (semaglutide) because appetite and cravings return, often regaining two-thirds of lost weight within a year, but this can be mitigated by gradual tapering, sustained exercise, and a healthy diet to manage the underlying chronic nature of obesity, says this source, this source, this source, and this source.
While you can stop Ozempic "cold turkey" without dangerous withdrawal symptoms, a gradual reduction might help your body adjust more easily. Some healthcare providers recommend tapering with lower doses before stopping completely. This approach might help with the transition as your body readjusts its hormone levels.
If you've gone longer than a week or two without the medication, using the drug again can provoke serious gastrointestinal side effects. You may need help from your clinician to get safely back on track.